Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncology Report

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.17.4.947PMID 17342341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin inhibits the growth of DMBA‐induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity

  2006cited by this paper
• Melatonin–estrogen interactions in breast cancer

  2005cited by this paper
• Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

  2005cited by this paper
• Melatonin modulates aromatase activity in MCF‐7 human breast cancer cells

  2005cited by this paper
• Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells

  2004cited by this paper
• Role of Hormones in Mammary Cancer Initiation and Progression

  2004cited by this paper
• The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.

  2003cited by this paper
• Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice.

  2003cited by this paper
• Melatonin and mammary cancer: a short review.

  2003cited by this paper
• MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.

  2002cited by this paper
• Involvement of the mt1 melatonin receptor in human breast cancer.

  2002cited by this paper
• Differential responsiveness of MCF‐7 human breast cancer cell line stocks to the pineal hormone, melatonin

  2000cited by this paper
• Melatonin and mammary pathological growth.

  2000cited by this paper
• Melatonin, experimental basis for a possible application in breast cancer prevention and treatment.

  2000cited by this paper
• Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity.

  1999cited by this paper
• Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors.

  1998cited by this paper
• Cellular mechanisms of melatonin action.

  1998cited by this paper
• Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.

  1998cited by this paper
• Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily.

  1997cited by this paper
• Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase

  1997cited by this paper
• Identification of a Promoter That Controls Aromatase Expression in Human Breast Cancer and Adipose Stromal Cells*

  1996cited by this paper
• Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene.

  1996cited by this paper
• Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses.

  1994cited by this paper
• Aromatase gene is amplified in MCF-7 human breast cancer cells.

  1993cited by this paper
• Histopathologic Features of DMBA‐Induced Mammary Tumors in Blind‐Underfed, Blind‐Anosmic, and Blind Cold‐Exposed Rats: Influence of the Pineal Gland

  1989cited by this paper
• Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture.

  1981cited by this paper
• Androgen action through estrogen receptor in a human breast cancer cell line.

  1978cited by this paper

• Melatonin in Endometriosis: Mechanistic Understanding and Clinical Insight

  2022cites this paper
• Activation of melatonin receptor 1 by CRISPR‐Cas9 activator ameliorates cognitive deficits in an Alzheimer's disease mouse model

  2022cites this paper
• Melatonin: A Potential Antineoplastic Agent in Breast Cancer.

  2022cites this paper
• Melatonin as an Oncostatic Molecule Based on Its Anti-Aromatase Role in Breast Cancer

  2021cites this paper
• Melatonin: A Potential Therapeutic Option for Breast Cancer

  2020cites this paper
• Melatonin: an endogenous miraculous indolamine, fights against cancer progression

  2020cites this paper
• Exogenous melatonin advances the ram breeding season and increases testicular function

  2020cites this paper
• Melatonin: A Molecule for Reducing Breast Cancer Risk

  2018cites this paper
• Carnosic acid cooperates with tamoxifen to induce apoptosis associated with Caspase-3 activation in breast cancer cells in vitro and in vivo.

  2017cites this paper
• Melatonin as a Medicament for the 24/7 Society: Cancer

  2016cites this paper
• Melatonin attenuated adipogenesis through reduction of the CCAAT/enhancer binding protein beta by regulating the glycogen synthase 3 beta in human mesenchymal stem cells

  2016cites this paper
• Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis.

  2016cites this paper
• Melatonin-Induced Oncostasis, Mechanisms and Clinical Relevance

  2016cites this paper
• Effect of Viola odorata Extract on Cell Survival of Triple Negative Breast Cancer MDA-MB-468 Cells

  2016cites this paper
• [Expression of melatonin receptors genes and genes associated with regulation of their activity in endometrial cancer].

  2015cites this paper
• Melatonin: an inhibitor of breast cancer.

  2015cites this paper
• An insight into the scientific background and future perspectives for the potential uses of melatonin

  2015cites this paper
• Melatonin modulation of cross talk among malignant epithelial , endothelial and adipose cells in breast cancer ( Review )

  2014cites this paper
• Circadian molecular clocks and cancer.

  2014cites this paper
• Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night

  2014cites this paper
• Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)

  2014cites this paper
• Expression of MT2 Receptor in Patients with Gastric Adenocarcinoma and its Relationship with Clinicopathological Features

  2014cites this paper
• Melatonin and Melatonergic Drugs for Therapeutic Use in Breast Cancer

  2014cites this paper
• Evaluation of inhibitory effect of melatonin on gastric adenocarcinoma AGS and MKN45 cell lines

  2013cites this paper
• Trabajo en turnos, privación de sueño y sus consecuencias clínicas y médicolegales

  2013cites this paper
• Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation.

  2013cites this paper
• Melatonin and Aromatase in Breast Cancer

  2013cites this paper
• Melatonin modulates aromatase activity and expression in endothelial cells.

  2013cites this paper
• The effect of exogenous melatonin during the non-reproductive season on the seminal plasma hormonal profile and the antioxidant defence system of Rasa Aragonesa rams.

  2013cites this paper
• Molecular mechanisms of melatonin’s inhibitory actions on breast cancers

  2013cites this paper
• Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma

  2013cites this paper
• Melatonin and Breast Cancer: Selective Estrogen Enzyme Modulator Actions

  2013cites this paper
• The circadian clock and the cell cycle

  2012cites this paper
• Gender‐related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer

  2012cites this paper
• Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts

  2012cites this paper
• Melatonin pathway genes and breast cancer risk among Chinese women

  2012cites this paper
• Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival

  2012cites this paper
• ROLA MELATONINY W PROCESACH ANTYNOWOTWOROWYCH — POTENCJALNE MECHANIZMY

  2011cites this paper
• [Anticarcinogenic role of melatonin--potential mechanisms].

  2011cites this paper
• Basic mechanisms involved in the anti-cancer effects of melatonin.

  2010cites this paper
• In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

  2010cites this paper
• Inhibitory effects of melatonin on sulfatase and 17beta-hydroxysteroid dehydrogenase activity and expression in glioma cells.

  2010cites this paper
• Ist psychischer Stress ein Risikofaktor bei der Entstehung und Entwicklung von Tumoren?

  2009cites this paper
• Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort

  2009cites this paper
• The Protective Role of Melatonin in Breast Cancer

  2009cites this paper
• Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

  2009cites this paper
• Melatonin as a selective estrogen enzyme modulator.

  2008cites this paper
• Melatonin and the hair follicle

  2007cites this paper
• 4. Mechanistic and Other Relevant Data 4.1 the Pineal Gland and Melatonin

  year unknowncites this paper